Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT)

There are substantial disease and health-related quality-of-life (HRQoL) burdens for many patients with myasthenia gravis (MG), especially for those whose disease symptoms are not well controlled. HRQoL measures such as the Myasthenia Gravis Quality of Life 15-item revised (MG-QOL15r) and EuroQoL 5-...

Descripción completa

Detalles Bibliográficos
Autores principales: Saccà, Francesco, Barnett, Carolina, Vu, Tuan, Peric, Stojan, Phillips, Glenn A., Zhao, Sihui, Qi, Cynthia Z., Gelinas, Deborah, Chiroli, Silvia, Verschuuren, Jan J. G. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025199/
https://www.ncbi.nlm.nih.gov/pubmed/36598575
http://dx.doi.org/10.1007/s00415-022-11517-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025199/
https://www.ncbi.nlm.nih.gov/pubmed/36598575
http://dx.doi.org/10.1007/s00415-022-11517-w

Ejemplares similares